Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Aveanna Healthcare Holdings, Inc. (AVAH)

Aveanna Q2 2026 revenue rises 13.7% to $670.5 million; adjusted EBITDA up 8.0%

Positive Impact 3 of 5 earnings Written later

Aveanna Healthcare filed an August 2026 investor presentation under Form 8-K showing second-quarter 2026 revenue of $670.5 million, up 13.7% from $589.6 million a year earlier. Adjusted EBITDA, a non-GAAP measure, rose 8.0% to $95.4 million, though gross margin as a percentage of revenue was lower than in the prior-year quarter, and the company reiterated 2026 guidance of more than $2.68 billion in revenue and more than $365 million in adjusted EBITDA.

Key points

  • Q2 2026 revenue $670.5 million, up 13.7% from $589.6 million in Q2 2025
  • Q2 2026 gross margin $218.5 million, up 3.7%; adjusted EBITDA $95.4 million, up 8.0%
  • Free cash flow of $75.4 million for 2026 to date, a $38.5 million improvement over 2025
  • 2026 guidance: revenue above $2.68 billion and adjusted EBITDA above $365 million

The filing

CompanyAveanna Healthcare Holdings, Inc. (AVAH)
Form8-K, current report
Filed with the SECAug 13, 2026, 7:00 AM ET
Accession number0001193125-26-347840

Items reported: 7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.